Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging

Radiology

Volumn 272, Issue 1, 2014, Pages 132-142

  Davenport, Matthew S ^a   Khalatbari, Shokoufeh ^a   Liu, Peter S C ^a   Maturen, Katherine E ^a   Kaza, Ravi K ^a   Wasnik, Ashish P ^a   Al Hawary, Mahmoud M ^a   Glazer, Daniel I ^a   Stein, Erica B ^a   Patel, Jeet ^a   Somashekar, Deepak K ^a   Viglianti, Benjamin L ^a   Hussain, Hero K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES; ARTERIAL HYPERENHANCEMENT; ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER IMAGING REPORTING AND DATA SYSTEM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVER VARIATION; ORGAN PROCUREMENT AND TRANSPLANTATION NETWORK; PRIORITY JOURNAL; PSEUDOCAPSULE; RADIOLOGIST; RETROSPECTIVE STUDY; SCORING SYSTEM; WASHOUT APPEARANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CLINICAL COMPETENCE; CONTRAST MEDIA; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84903697416     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14131963     Document Type: Article

References (12)

1. HRSA/OPTN. Policy 3.6 organ distribution: allocation of livers. http://optn.transplant.hrsa.gov/policiesAndBylaws/policies.asp. Published 2012. Accessed July 27, 2013.
2. Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 2013;266(2):376-382.
3. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011;53(3):1020-1022.
4. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008;247(2):311-330.
5. Pomfret EA, Washburn K, Wald C, et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010;16(3):262-278.
6. American College of Radiology. Liver Imaging Reporting and Data System version 2013.1. http://www.acr.org/Quality-Safety/Resources/LIRADS/. Published 2013. Accessed January 2013.
7. Clavien PA, Lesurtel M, Bossuyt PM, et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 2012;13(1):e11-e22.
8. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334(11):693-699. (Pubitemid 26079803)
9. Mazzaferro V, Bhoori S, Sposito C, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl 2011;17(Suppl 2):S44-S57.
10. Medical Imaging Resource Center (MIRC) Digital Imaging and Communications in Medicine. (DICOM) Anonymizer. Radiological Society of North America. http://mircwiki.rsna. org/index.php?title=The-MIRC-DICOM-Anonymizer. Accessed January 29, 2014.
11. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med 2005;37(5):360-363. (Pubitemid 40656185)
12. American College of Radiology. Breast Imaging Reporting and Data System, 4th ed. http://www.acr.org/Quality-Safety/Resources/BIRADS/Mammography. Accessed January 29, 2014.